Literature DB >> 17414736

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Viktor Y Dombrovskiy1, Andrew A Martin, Jagadeeshan Sunderram, Harold L Paz.   

Abstract

OBJECTIVE: To determine recent trends in rates of hospitalization, mortality, and hospital case fatality for severe sepsis in the United States.
DESIGN: Trend analysis for the period from 1993 to 2003.
SETTING: U.S. community hospitals from the Nationwide Inpatient Sample that is a 20% stratified sample of all U.S. community hospitals. PATIENTS: Subjects of any age with sepsis including severe sepsis who were hospitalized in the United States during the study period.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Utilizing International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for septicemia and major organ dysfunction, we identified 8,403,766 patients with sepsis, including 2,857,476 patients with severe sepsis, who were hospitalized in the United States from 1993 to 2003. The percentage of severe sepsis cases among all sepsis cases increased continuously from 25.6% in 1993 to 43.8% in 2003 (p < .001). Age-adjusted rate of hospitalization for severe sepsis grew from 66.8 +/- 0.16 to 132.0 +/- 0.21 per 100,000 population (p < .001). Age-adjusted, population-based mortality rate within these years increased from 30.3 +/- 0.11 to 49.7 +/- 0.13 per 100,000 population (p < .001), whereas hospital case fatality rate fell from 45.8% +/- 0.17% to 37.8% +/- 0.10% (p < .001). During each study year, the rates of hospitalization, mortality, and case fatality increased with age. Hospitalization and mortality rates in males exceeded those in females, but case fatality rate was greater in females. From 1993 to 2003, age-adjusted rates for severe sepsis hospitalization and mortality increased annually by 8.2% (p < .001) and 5.6% (p < .001), respectively, whereas case fatality rate decreased by 1.4% (p < .001).
CONCLUSIONS: The rate of severe sepsis hospitalization almost doubled during the 11-yr period studied and is considerably greater than has been previously predicted. Mortality from severe sepsis also increased significantly. However, case fatality rates decreased during the same study period.

Entities:  

Mesh:

Year:  2007        PMID: 17414736     DOI: 10.1097/01.CCM.0000261890.41311.E9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  466 in total

1.  [Prognostic value of difference between peripheral venous and arterial partial pressure of carbon dioxide in patients with septic shock: a pilot study].

Authors:  Wei Gao; Yong Zhang; Haibin Ni; Jialiu Zhang; Dandan Zhou; Liping Yin; Feng Zhang; Hao Chen; Beibei Zhang; Wei Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis.

Authors:  Hong Feng; Ling Guo; Zhiqing Song; Haiqing Gao; Dan Wang; Weisi Fu; Jingyan Han; Zhenyu Li; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  Peripherally inserted central catheters are equivalent to centrally inserted catheters in intensive care unit patients for central venous pressure monitoring.

Authors:  Heath E Latham; Scott T Rawson; Timothy T Dwyer; Chirag C Patel; Jo A Wick; Steven Q Simpson
Journal:  J Clin Monit Comput       Date:  2012-04       Impact factor: 2.502

4.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

Review 5.  Update in hospital medicine for the general internist 2010-2011.

Authors:  Romsai T Boonyasai; Daniel I Steinberg; Anneliese M Schleyer; Michelle M Mourad; Brian J Harte; Bradley A Sharpe
Journal:  J Gen Intern Med       Date:  2011-09-20       Impact factor: 5.128

Review 6.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

7.  Merinoff symposium 2010: sepsis--an international call to action.

Authors:  Christopher J Czura
Journal:  Mol Med       Date:  2010 May-Jun       Impact factor: 6.354

8.  Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting.

Authors:  Martin Christner; Holger Rohde; Manuel Wolters; Ingo Sobottka; Karl Wegscheider; Martin Aepfelbacher
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

9.  Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population.

Authors:  Stacey-Ann Whittaker; Mark E Mikkelsen; David F Gaieski; Sherine Koshy; Craig Kean; Barry D Fuchs
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

10.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.